by admin | Nov 11, 2019 | FDA
The Food and Drug Administration has given the go-ahead to what it calls the first next-generation sequencing test for detecting mutations that enable the most common strain of HIV to become immune to drugs. The FDA said that it had authorized marketing of...
by admin | Nov 4, 2019 | Partnerships
PredictImmune, developers of pioneering prognostic tools for guiding treatment options in immune-mediated diseases, confirmed that it has entered into a commercial partnership with Theradiag, a pioneering European diagnostic company specialising in in vitro...
by admin | Nov 4, 2019 | Funding
The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs. A startup that aims to provide a software-as-a-service platform to allow genomic...
by admin | Sep 25, 2019 | Funding
HTG Molecular Diagnostics Announces Completion of $22.5 Million Aggregate Financing, Consisting of $19.0 Million Public Offering of Common Stock, Including the Exercise in Full of the Underwriter’s Option to Purchase Additional Shares, and $3.5 Million Concurrent...
by admin | Sep 6, 2019 | FDA
Prescient Metabiomics has received FDA breakthrough status for its non-invasive colorectal cancer test. The test, called LifeKit Prevent, identifies microbial DNA and RNA biomarkers associated with the new, abnormal growth of tissue in the gastrointestinal tract. By...
